Bereich
Infektiologie | Infektionsprävention | Reisemedizin
INFEKT · Dept. I
AmpC hyperproduction in a Cedecea davisae implant-associated bone infection during treatment: a case report and therapeutic implications.
Notter J, Seiffert S, Zimmermann-Kogadeeva M, Bösch A, Wenger R, Strahm C, Frischknecht M, Livermore D, Babouee Flury B. AmpC hyperproduction in a Cedecea davisae implant-associated bone infection during treatment: a case report and therapeutic implications. BMC Infect Dis 2022; 22:33.
06.01.2022AmpC hyperproduction in a Cedecea davisae implant-associated bone infection during treatment: a case report and therapeutic implications.
06.01.2022BMC Infect Dis 2022; 22:33
Notter Julia, Seiffert Salome N, Zimmermann-Kogadeeva Maria, Bösch Anja, Wenger Robert, Strahm Carol, Frischknecht Manuel, Livermore David M, Babouee Flury Baharak
The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).
König R, Albrich W, Kahlert C, Bahr L, Löber U, Vernazza P, Scheibenbogen C, Forslund S. The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS). Front Immunol 2022; 12:628741.
03.01.2022The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).
03.01.2022Front Immunol 2022; 12:628741
König Rahel S, Albrich Werner, Kahlert Christian, Bahr Lina Samira, Löber Ulrike, Vernazza Pietro, Scheibenbogen Carmen, Forslund Sofia K
A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2.
Albrich W, Ghosh T, Ahearn-Ford S, Mikaeloff F, Lunjani N, Forde B, Suh N, Kleger G, Pietsch U, Frischknecht M, Garzoni C, Forlenza R, Horgan M, Sadlier C, Negro T, Pugin J, Wozniak H, Cerny A, Neogi U, O'Toole P, O'Mahony L. A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2. Gut Microbes 2022; 14:2073131.
01.01.2022A high-risk gut microbiota configuration associates with fatal hyperinflammatory immune and metabolic responses to SARS-CoV-2.
01.01.2022Gut Microbes 2022; 14:2073131
Albrich Werner, Ghosh Tarini Shankar, Ahearn-Ford Sinead, Mikaeloff Flora, Lunjani Nonhlanhla, Forde Brian, Suh Noémie, Kleger Gian-Reto, Pietsch Urs, Frischknecht Manuel, Garzoni Christian, Forlenza Rossella, Horgan Mary, Sadlier Corinna, Negro Tommaso Rochat, Pugin Jérôme, Wozniak Hannah, Cerny Andreas, Neogi Ujjwal, O'Toole Paul W, O'Mahony Liam
[Non-antibiotic Prophylaxis of Infections].
Seneghini M, Albrich W. [Non-antibiotic Prophylaxis of Infections]. Praxis (Bern 1994) 2022; 111:463-468.
01.01.2022[Non-antibiotic Prophylaxis of Infections].
01.01.2022Praxis (Bern 1994) 2022; 111:463-468
Seneghini Marco, Albrich Werner
SwissPedData: Standardising hospital records for the benefit of paediatric research
Jaboyedoff M, Kopp M, Lauener R, Neuhaus T, Paioni P, Posfay-Barbe K, Ramelli G, Simeoni U, Simonetti G, Sokollik C, Spycher B, Kaiser D, Kahlert C, Rakic M, Bachmann S, Christoph B, Diezi M, Fuchs O, Frey U, Gervaix A, Glücksberg A, Grotzer M, Heininger U, Kuehni C. SwissPedData: Standardising hospital records for the benefit of paediatric research. Swiss Med Wkly 2021; 151:w30069.
21.12.2021SwissPedData: Standardising hospital records for the benefit of paediatric research
21.12.2021Swiss Med Wkly 2021; 151:w30069
Jaboyedoff Manon, Kopp Matthias V, Lauener Roger, Neuhaus Thomas J, Paioni Paolo, Posfay-Barbe Klara, Ramelli Gian Paolo, Simeoni Umberto, Simonetti Giacomo, Sokollik Christiane, Spycher Ben D, Kaiser Daniela, Kahlert Christian, Rakic Milenko, Bachmann Sara, Christoph Berger, Diezi Manuel, Fuchs Oliver, Frey Urs, Gervaix Alain, Glücksberg Amalia Stefani, Grotzer Michael, Heininger Ulrich, Kuehni Claudia E
Distribution of Species and Prevalence of Azole Resistance in Respiratory Samples From Swiss Tertiary Care Hospitals
Ragozzino S, Lamoth F, Zbinden R, Schreiber P, Fankhauser H, Conen A, Nolte O, Boggian K, Riat A, Neofytos D, Mühlethaler K, Zimmerli S, Wright P, Goldenberger D, Khanna N. Distribution of Species and Prevalence of Azole Resistance in Respiratory Samples From Swiss Tertiary Care Hospitals. Open Forum Infect Dis 2021; 9:ofab638.
18.12.2021Distribution of Species and Prevalence of Azole Resistance in Respiratory Samples From Swiss Tertiary Care Hospitals
18.12.2021Open Forum Infect Dis 2021; 9:ofab638
Ragozzino Silvio, Lamoth Frédéric, Zbinden Reinhard, Schreiber Peter W, Fankhauser Hans, Conen Anna, Nolte Oliver, Boggian Katia, Riat Arnaud, Neofytos Dionysios, Mühlethaler Konrad, Zimmerli Stefan, Wright Patrick R, Goldenberger Daniel, Khanna Nina
No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: a prospective healthcare worker study
Kohler P, Jonsdottir H, Risch L, Vernazza P, Ackermann-Gäumann R, Kahlert C. No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: a prospective healthcare worker study. Sci Rep 2021; 11:24198.
17.12.2021No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: a prospective healthcare worker study
17.12.2021Sci Rep 2021; 11:24198
Kohler Philipp, Jonsdottir Hulda R, Risch Lorenz, Vernazza Pietro, Ackermann-Gäumann Rahel, Kahlert Christian
Telomere Length Declines In Persons Living With HIV Before Antiretroviral Therapy Start But Not After Viral Suppression: A Longitudinal Study Over >17 Years
Schoepf I, Bernasconi E, Cavassini M, Buvelot H, Arribas J, Kouyos R, Fellay J, Günthard H, Tarr P, Seneghini M, Marzolini C, Thurnheer C, Thorball C, Ledergerber B, Kootstra N, Reiss P, Raffenberg M, Engel T, Braun D, Hasse B, Swiss HIV Cohort Study. Telomere Length Declines In Persons Living With HIV Before Antiretroviral Therapy Start But Not After Viral Suppression: A Longitudinal Study Over >17 Years. J Infect Dis 2021
15.12.2021Telomere Length Declines In Persons Living With HIV Before Antiretroviral Therapy Start But Not After Viral Suppression: A Longitudinal Study Over >17 Years
15.12.2021J Infect Dis 2021
Schoepf Isabella C, Bernasconi Enos, Cavassini Matthias, Buvelot Hélène, Arribas José R, Kouyos Roger D, Fellay Jacques, Günthard Huldrych F, Tarr Philip E, Seneghini Marco, Marzolini Catia, Thurnheer Christine, Thorball Christian W, Ledergerber Bruno, Kootstra Neeltje A, Reiss Peter, Raffenberg Marieke, Engel Tanja, Braun Dominique L, Hasse Barbara, Swiss HIV Cohort Study
Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer.
Bösch M, Baty F, Albrich W, Flatz L, Rodriguez R, Rothschild S, Jörger M, Früh M, Brutsche M. Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer. Oncoimmunology 2021; 10:1988403.
10.12.2021Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer.
10.12.2021Oncoimmunology 2021; 10:1988403
Bösch Maximilian, Baty Florent, Albrich Werner, Flatz Lukas, Rodriguez Regulo, Rothschild Sacha I, Jörger Markus, Früh Martin, Brutsche Martin H
Infektiologische Probleme in der Onkologie
Boggian K. Infektiologische Probleme in der Onkologie. OncoMag 2021; 4:30-35.
01.12.2021Infektiologische Probleme in der Onkologie
01.12.2021OncoMag 2021; 4:30-35
Boggian Katia
Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV
Damas J, Hundsberger T, Di Benedetto C, Rossi S, Hasse B, Schlosser L, Du Pasquier R, Darling K, Cavassini M, Schmid P, Assal F, Ledergerber B, Nadin I, Tarr P, Stoeckle M, Kunze U, Hauser C, Gutbrod K, Calmy A, and the NAMACO study group. Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV. AIDS 2021; 35:2469-2480.
01.12.2021Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV
01.12.2021AIDS 2021; 35:2469-2480
Damas José, Hundsberger Thomas, Di Benedetto Caroline, Rossi Stefania, Hasse Barbara, Schlosser Ladina, Du Pasquier Renaud, Darling Katharine E A, Cavassini Matthias, Schmid Patrick, Assal Frédéric, Ledergerber Bruno, Nadin Isaure, Tarr Philip E, Stoeckle Marcel, Kunze Ursi, Hauser Christoph, Gutbrod Klemens, Calmy Alexandra, and the NAMACO study group
Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR)
Roelens M, Schreiber P, Sommerstein R, Troillet N, Tschudin-Sutter S, Vetter P, Bernhard-Stirnemann S, Corti N, Gaudenz R, Marschall J, Nussbaumer-Ochsner Y, Senn L, Vuichard-Gysin D, Zimmermann P, Zucol F, Iten A, Riedel T, Niederer-Loher A, Martin A, Friker B, Sousa F, Thiabaud A, Vidondo B, Buchter V, Gardiol C, Vonlanthen J, Balmelli C, Battegay M, Christoph B, Buettcher M, Cusini A, Flury D, Heininger U, Keiser O. Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR). Swiss Med Wkly 2021; 151:w30105.
24.11.2021Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR)
24.11.2021Swiss Med Wkly 2021; 151:w30105
Roelens Maroussia, Schreiber Peter W, Sommerstein Rami, Troillet Nicolas, Tschudin-Sutter Sarah, Vetter Pauline, Bernhard-Stirnemann Sara, Corti Natascia, Gaudenz Roman, Marschall Jonas, Nussbaumer-Ochsner Yvonne, Senn Laurence, Vuichard-Gysin Danielle, Zimmermann Petra, Zucol Franziska, Iten Anne, Riedel Thomas, Niederer-Loher Anita, Martin Alexis, Friker Brian, Sousa Filipe Maximiano, Thiabaud Amaury, Vidondo Beatriz, Buchter Valentin, Gardiol Céline, Vonlanthen Jasmin, Balmelli Carlo, Battegay Manuel, Christoph Berger, Buettcher Michael, Cusini Alexia, Flury Domenica, Heininger Ulrich, Keiser Olivia
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food-A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper.
Zuberbier T, Dörr T, Aberer W, Alvaro-Lozano M, Angier E, Arasi S, Arshad H, Ballmer-Weber B, Bartra J, Beck L, Bégin P, Bindslev-Jensen C, Bislimovska J, Bousquet J, Brockow K, Bush A, Cianferoni A, Cork M, Custovic A, Darsow U, de Jong N, Deleanu D, Del Giacco S, Deschildre A, Dunn Galvin A, Ebisawa M, Fernández-Rivas M, Ferrer M, Fiocchi A, Gerth van Wijk R, Gotua M, Grimshaw K, Grünhagen J, Heffler E, Hide M, Hoffmann-Sommergruber K, Incorvaia C, Janson C, John S, Jones C, Jutel M, Katoh N, Kendziora B, Kinaciyan T, Knol E, Kurbacheva O, Lau S, Loh R, Lombardi C, Mäkelä M, Marchisotto M, Makris M, Maurer M, Meyer R, Mijakoski D, Minov J, Mullol J, Nilsson C, Nowak-Wegrzyn A, Nwaru B, Odemyr M, Pajno G, Paudel S, Papadopoulos N, Renz H, Ricci G, Ring J, Rogala B, Sampson H, Senna G, Sitkauskiene B, Smith P, Stevanovic K, Stoleski S, Szajewska H, Tanaka A, Todo-Bom A, Topal F, Valovirta E, Van Ree R, Venter C, Wöhrl S, Wong G, Zhao Z, Worm M. Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food-A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper. Allergy 2021; 77:1736-1750.
24.11.2021Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food-A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper.
24.11.2021Allergy 2021; 77:1736-1750
Zuberbier Torsten, Dörr Tamara, Aberer Werner, Alvaro-Lozano Montserrat, Angier Elizabeth, Arasi Stefania, Arshad Hasan, Ballmer-Weber Barbara, Bartra Joan, Beck Lisa, Bégin Philippe, Bindslev-Jensen Carsten, Bislimovska Jovanka, Bousquet Jean, Brockow Knut, Bush Andrew, Cianferoni Antonella, Cork Michael J, Custovic Adnan, Darsow Ulf, de Jong Nicolette, Deleanu Diana, Del Giacco Stefano, Deschildre Antoine, Dunn Galvin Audrey, Ebisawa Motohiro, Fernández-Rivas Montserrat, Ferrer Marta, Fiocchi Alessandro, Gerth van Wijk Roy, Gotua Maia, Grimshaw Kate E C, Grünhagen Josefine, Heffler Enrico, Hide Michihiro, Hoffmann-Sommergruber Karin, Incorvaia Cristoforo, Janson Christer, John Swen Malte, Jones Carla, Jutel Marek, Katoh Norito, Kendziora Benjamin, Kinaciyan Tamar, Knol Edward, Kurbacheva Oksana, Lau Susanne, Loh Richard, Lombardi Carlo, Mäkelä Mika, Marchisotto Mary Jane, Makris Michael, Maurer Marcus, Meyer Rosan, Mijakoski Dragan, Minov Jordan, Mullol Joaquim, Nilsson Caroline, Nowak-Wegrzyn Anna, Nwaru Bright I, Odemyr Mikela, Pajno Giovanni Battista, Paudel Sushil, Papadopoulos Nikolaos G, Renz Harald, Ricci Giampaolo, Ring Johannes, Rogala Barbara, Sampson Hugh A, Senna Gianenrico, Sitkauskiene Brigita, Smith Peter Kenneth, Stevanovic Katarina, Stoleski Sasho, Szajewska Hania, Tanaka Akio, Todo-Bom Ana, Topal Fatih Alexander, Valovirta Erkka, Van Ree Ronald, Venter Carina, Wöhrl Stefan, Wong George K C, Zhao Zuotao, Worm Margitta
Digital SARS-CoV-2 Detection Among Hospital Employees: Participatory Surveillance Study
Leal-Neto O, Kahlert C, Vernazza P, Kuster S, Babouee Flury B, Albrich W, Sumer J, Flury D, Schlegel M, Egger T, Kohler P. Digital SARS-CoV-2 Detection Among Hospital Employees: Participatory Surveillance Study. JMIR Public Health Surveill 2021; 7:e33576.
22.11.2021Digital SARS-CoV-2 Detection Among Hospital Employees: Participatory Surveillance Study
22.11.2021JMIR Public Health Surveill 2021; 7:e33576
Leal-Neto Onicio, Kahlert Christian, Vernazza Pietro, Kuster Stefan, Babouee Flury Baharak, Albrich Werner, Sumer Johannes, Flury Domenica, Schlegel Matthias, Egger Thomas, Kohler Philipp
Decreasing incidence and determinants of Bacterial Pneumonia in people with HIV: The Swiss HIV Cohort Study
Balakrishna S, Günthard H, Battegay M, Bernasconi E, Schmid P, Cavassini M, Calmy A, Hauser C, Furrer H, Scherrer A, Kusejko K, Roth J, Kachalov V, Wolfensberger A, Kouyos R. Decreasing incidence and determinants of Bacterial Pneumonia in people with HIV: The Swiss HIV Cohort Study. J Infect Dis 2021
18.11.2021Decreasing incidence and determinants of Bacterial Pneumonia in people with HIV: The Swiss HIV Cohort Study
18.11.2021J Infect Dis 2021
Balakrishna Suraj, Günthard Huldrych F, Battegay Manuel, Bernasconi Enos, Schmid Patrick, Cavassini Matthias, Calmy Alexandra, Hauser Christoph, Furrer Hansjakob, Scherrer Alexandra U, Kusejko Katharina, Roth Jan A, Kachalov Viacheslav, Wolfensberger Aline, Kouyos Roger D
Behandlung der Streptokokkenangina ohne Antibiotika
Berger H, Hetzel P, Simma L, Guggenheim R, Stöckli S, Cao Van H, Pandolfi F, Etter G, Gallmann C, Christinet V, Avoledo P, Rowedder A, Hasse B, Posfay-Barbe K, Senn L, Merz A, Peters N, Hofmann Y, Wingeier B, Huber B, Boggian K, Hug-Batschelet H, Rosamilia C, Mosimann P, Bielicki J, Horvath L, Hotz M, Dettwiler A, Fluri S, Diana A, Von Schön-Angerer T, Tarr P. Behandlung der Streptokokkenangina ohne Antibiotika. Primary and Hospital Care 2021; 21:360-367.
03.11.2021Behandlung der Streptokokkenangina ohne Antibiotika
03.11.2021Primary and Hospital Care 2021; 21:360-367
Berger Hanna, Hetzel Patrick, Simma Leopold, Guggenheim RAffael, Stöckli Sandro, Cao Van Helene, Pandolfi Fabio, Etter Gisela, Gallmann Caesar, Christinet Vanessa, Avoledo Pierino, Rowedder Axel, Hasse Barbara, Posfay-Barbe Klara, Senn Laurence, Merz Adrian, Peters Nienske, Hofmann Yael, Wingeier Bernhard, Huber Benedikt, Boggian Katia, Hug-Batschelet Henriette, Rosamilia Claudia, Mosimann Philippe, Bielicki Julia, Horvath Lukas, Hotz Michel-Andre, Dettwiler Andreas, Fluri Simon, Diana Alessandro, Von Schön-Angerer Tido, Tarr Philip
Behandlung der Streptokokkenangina ohne Antibiotika
Berger H, Hetzel P, Simma L, Guggenheim R, Stöckli S, CAo V, Pandolfi F, Etter G, Gallmann C, Christinet V, Avoledo P, Rowedder A, Hasse B, Posfay-Barbe K, Senn L, Merz A, Peters N, Hofmann Y, Wingeier B, Huber B, Boggian K, Hug-Batschelett H, Rosamilia C, Mosimann P, Bielicki J, Horvath L, Hotz M, Dettwiler A, Furi S, Diana A, Von Schön-Angerer T, Tarr P. Behandlung der Streptokokkenangina ohne Antibiotika. Primary and Hospital Care 2021; 21:360-367.
03.11.2021Behandlung der Streptokokkenangina ohne Antibiotika
03.11.2021Primary and Hospital Care 2021; 21:360-367
Berger Hanna, Hetzel Patrick, Simma Leopold, Guggenheim RAffael, Stöckli Sandro, CAo Van Helene, Pandolfi Fabio, Etter Gisela, Gallmann Caesar, Christinet Vanessa, Avoledo Pierino, Rowedder Axel, Hasse Barbara, Posfay-Barbe Klara, Senn Laurence, Merz Adrian, Peters Nienske, Hofmann Yael, Wingeier Bernhard, Huber Benedikt, Boggian Katia, Hug-Batschelett Henriette, Rosamilia Claudia, Mosimann Philippe, Bielicki Julia, Horvath Lukas, Hotz Michel-Andre, Dettwiler Andreas, Furi Simon, Diana Alessandro, Von Schön-Angerer Tido, Tarr Philip
Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.
Hasan Ali O, Bomze D, Risch L, Brugger S, Paprotny M, Weber M, Thiel S, Kern L, Albrich W, Kohler P, Kahlert C, Vernazza P, Bühler P, Schüpbach R, Gómez-Mejia A, Popa A, Bergthaler A, Penninger J, Flatz L. Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies. Clin Infect Dis 2021; 73:1746.
02.11.2021Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.
02.11.2021Clin Infect Dis 2021; 73:1746
Hasan Ali Omar, Bomze David, Risch Lorenz, Brugger Silvio D, Paprotny Matthias, Weber Myriam, Thiel Sarah, Kern Lukas, Albrich Werner, Kohler Philipp, Kahlert Christian, Vernazza Pietro, Bühler Philipp K, Schüpbach Reto A, Gómez-Mejia Alejandro, Popa Alexandra M, Bergthaler Andreas, Penninger Josef M, Flatz Lukas
Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018
Barnsteiner S, Kohler P, Kronenberg A, Schlegel M, Plüss-Suard C, Gasser M, Babouee Flury B, Albrich W, Baty F, Swiss Centre for Antibiotic Resistance (ANRESIS). Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018. Euro Surveill 2021; 26
01.11.2021Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018
01.11.2021Euro Surveill 2021; 26
Barnsteiner Stefanie, Kohler Philipp, Kronenberg Andreas, Schlegel Matthias, Plüss-Suard Catherine, Gasser Michael, Babouee Flury Baharak, Albrich Werner, Baty Florent, Swiss Centre for Antibiotic Resistance (ANRESIS)
Assessing the drivers of syphilis among men who have sex with men in Switzerland reveals a key impact of screening frequency: A modelling study
Balakrishna S, Kouyos R, Rauch A, Günthard H, Bernasconi E, Schmid P, Battegay M, Cavassini M, Nicca D, Roth J, Thurnheer M, Kusejko K, Kachalov V, Schmidt A, Salazar-Vizcaya L, Swiss HIV Cohort Study (SHCS). Assessing the drivers of syphilis among men who have sex with men in Switzerland reveals a key impact of screening frequency: A modelling study. PLoS Comput Biol 2021; 17:e1009529.
26.10.2021Assessing the drivers of syphilis among men who have sex with men in Switzerland reveals a key impact of screening frequency: A modelling study
26.10.2021PLoS Comput Biol 2021; 17:e1009529
Balakrishna Suraj, Kouyos Roger D, Rauch Andri, Günthard Huldrych F, Bernasconi Enos, Schmid Patrick, Battegay Manuel, Cavassini Matthias, Nicca Dunja, Roth Jan A, Thurnheer Maria Christine, Kusejko Katharina, Kachalov Viacheslav, Schmidt Axel J, Salazar-Vizcaya Luisa, Swiss HIV Cohort Study (SHCS)